Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- 37 Endocarditis of natural and prosthetic valves: treatment and prophylaxis
- 38 Acute pericarditis
- 39 Myocarditis
- 40 Mediastinitis
- 41 Vascular infection
- 42 Infections of cardiovascular implantable electronic devices and VAD
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
42 - Infections of cardiovascular implantable electronic devices and VAD
from Part VI - Clinical syndromes: heart and blood vessels
Published online by Cambridge University Press: 05 April 2015
Edited by
Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- 37 Endocarditis of natural and prosthetic valves: treatment and prophylaxis
- 38 Acute pericarditis
- 39 Myocarditis
- 40 Mediastinitis
- 41 Vascular infection
- 42 Infections of cardiovascular implantable electronic devices and VAD
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 280 - 285Publisher: Cambridge University PressPrint publication year: 2015
References
, , , et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307(16):1727–1735.Google ScholarPubMed
, , , et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458–477.CrossRefGoogle ScholarPubMed
, . Cardiovascular implantable electronic device infection: a stepwise approach to diagnosis and management. Clev Clin J Med. 2011;78(8):529–537.CrossRefGoogle ScholarPubMed
, , , et al. Prospective, multicenter study of ventricular assist device infections. Circulation. 2013;127(6):691–702.CrossRefGoogle ScholarPubMed
, , , et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States. J Am Coll Cardiol. 2011;58(10):1001–1006.CrossRefGoogle ScholarPubMed
, , , et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis. J Am Coll Cardiol. 2012;59(7):681–687.CrossRefGoogle ScholarPubMed
, , , et al. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013;111(6):874–879.CrossRefGoogle ScholarPubMed
, , . Microbiology and pathogenesis of cardiovascular implantable electronic device infections. Circulation Arrhythm Electrophysiol. 2012;5(2):433–441.CrossRefGoogle ScholarPubMed
, , . Current concepts in the diagnosis and management of left ventricular assist device infections. Expert Rev Anti Infect Ther. 2013;11(2):201–210.CrossRefGoogle ScholarPubMed
, , , , . Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171(20):1821–1828.CrossRefGoogle ScholarPubMed
, , , et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851–1859.CrossRefGoogle ScholarPubMed
, , , . Surgical infection prophylaxis for left ventricular assist device implantation. J Card Surg. 2011;26(4):440–443.CrossRefGoogle ScholarPubMed